715104087	715104087	CD	B-NP	O
|	|	NN	I-NP	O
GAH	GAH	NN	I-NP	O
|	|	NN	I-NP	O
59562830	59562830	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
604523	604523	CD	B-NP	O
|	|	CC	I-NP	O
6/29/1997	6/29/1997	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
BREAST	BREAST	NNP	I-NP	I-protein
CARCINOMA	CARCINOMA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/14/1997	10/14/1997	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/16/1997	9/16/1997	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CELLULITIS	CELLULITIS	NN	B-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Fennessy	Fennessy	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
47-year-old	47-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
stage	stage	NN	B-NP	O
I	I	CD	I-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
spontaneous	spontaneous	JJ	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
breast	breast	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
last	last	JJ	B-NP	O
year	year	NN	I-NP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
breast	breast	NN	I-NP	O
mass	mass	NN	I-NP	O
approximately	approximately	RB	B-NP	O
4	4	CD	I-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
moderately	moderately	RB	B-NP	O
aggressive	aggressive	JJ	I-NP	O
histology	histology	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
node	node	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
and	and	CC	O	O
ERPR	ERPR	NN	B-ADJP	B-protein
negative	negative	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
cancer	cancer	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
T-2	T-2	NN	B-NP	O
,	,	,	O	O
N-0	N-0	NN	B-NP	B-protein
,	,	,	O	O
M-0	M-0	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
lumpectomy	lumpectomy	NN	B-NP	O
,	,	,	O	O
XRT	XRT	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
four	four	CD	B-NP	O
cycles	cycle	NNS	I-NP	O
of	of	IN	B-PP	O
CAF	CAF	NN	B-NP	B-protein
ending	end	VBG	B-VP	O
11/27	11/27	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
suffered	suffer	VBD	B-VP	O
significant	significant	JJ	B-NP	O
skin	skin	NN	I-NP	O
breakdown	breakdown	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
radiation	radiation	NN	I-NP	O
therapy	therapy	NN	I-NP	O
but	but	CC	O	O
improved	improve	VBN	B-VP	O
by	by	IN	B-PP	O
11/16	11/16	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
represented	represent	VBD	B-VP	O
in	in	IN	B-PP	O
6/20	6/20	CD	B-NP	O
with	with	IN	B-PP	O
two	two	CD	B-NP	O
areas	area	NNS	I-NP	O
of	of	IN	B-PP	O
erythema	erythema	NN	B-NP	O
with	with	IN	B-PP	O
underlying	underlie	VBG	B-VP	O
lumps	lump	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
outer	outer	JJ	I-NP	O
margin	margin	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
breast	breast	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
appearance	appearance	NN	I-NP	O
of	of	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
a	a	DT	B-NP	O
biopsy	biopsy	NN	I-NP	O
turned	turn	VBD	B-VP	O
out	out	RP	B-PRT	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
cancer	cancer	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
nafcillin	nafcillin	NN	B-NP	O
intravenously	intravenously	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
starting	start	VBG	B-VP	O
in	in	IN	B-PP	O
7/19	7/19	CD	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
dicloxacillin	dicloxacillin	NN	I-NP	O
since	since	IN	B-PP	O
then	then	RB	B-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
that	that	IN	I-SBAR	O
she	she	PRP	B-NP	O
could	could	MD	B-VP	O
take	take	VB	I-VP	O
antibiotics	antibiotic	NNS	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
skin	skin	NN	I-NP	O
changes	change	NNS	I-NP	O
have	have	VBP	B-VP	O
waxed	wax	VBN	I-VP	O
and	and	CC	I-VP	O
waned	wan	VBN	I-VP	O
since	since	IN	B-PP	O
then	then	RB	B-NP	O
so	so	IN	B-SBAR	O
that	that	IN	I-SBAR	O
some	some	DT	B-NP	O
physicians	physician	NNS	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
care	care	NN	I-NP	O
felt	feel	VBD	B-VP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
improvement	improvement	NN	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
clinical	clinical	JJ	I-NP	O
condition	condition	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
subjectively	subjectively	RB	B-ADVP	O
felt	feel	VBD	B-VP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
none	none	NN	B-NP	O
.	.	.	O	O

More	More	RBR	B-ADVP	O
recently	recently	RB	I-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
breast	breast	NN	I-NP	O
has	have	VBZ	B-VP	O
swollen	swell	VBN	I-VP	O
considerably	considerably	RB	B-ADVP	O
and	and	CC	O	O
the	the	DT	B-NP	O
overlying	overlie	VBG	I-NP	O
skin	skin	NN	I-NP	O
has	have	VBZ	B-VP	O
become	become	VBN	I-VP	O
erythematous	erythematous	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
erythema	erythema	NN	I-NP	O
has	have	VBZ	B-VP	O
spread	spread	VBN	I-VP	O
to	to	TO	I-VP	O
involve	involve	VB	I-VP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
breast	breast	NN	I-NP	O
and	and	CC	B-PP	O
around	around	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
back	back	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
fevers	fever	NNS	I-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
feels	feel	VBZ	B-VP	O
generally	generally	RB	B-ADVP	O
ill	ill	NN	B-NP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
never	never	RB	I-VP	O
been	be	VBN	I-VP	O
an	an	DT	B-NP	O
issue	issue	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
reported	report	VBD	B-VP	O
new	new	JJ	B-NP	O
left-sided	left-sided	JJ	I-NP	O
chest	chest	NN	I-NP	O
wall	wall	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	HYPH	B-NP	B-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	I-protein
Left	Leave	VBN	I-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
as	as	IN	B-PP	O
above	above	IN	B-PP	O
;	;	:	O	O
-LRB-	-LRB-	NN	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	:	O	O
Type	Type	NN	B-NP	O
II	II	CD	B-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
for	for	IN	B-PP	O
1-2	1-2	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
currently	currently	RB	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
diet	diet	NN	B-NP	O
and	and	CC	I-NP	O
exercise	exercise	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
takes	take	VBZ	B-VP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
frequently	frequently	RB	B-ADVP	O
and	and	CC	O	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
sugars	sugar	NNS	I-NP	O
are	be	VBP	B-VP	O
usually	usually	RB	B-ADVP	O
round	round	JJ	B-NP	O
100	100	CD	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Hypothyroidism	Hypothyroidism	NNP	I-NP	O
diagnosed	diagnose	VBD	B-VP	O
two	two	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
;	;	:	O	O
-LRB-	-LRB-	NN	B-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Low	Low	NNP	I-NP	O
back	back	RB	B-ADVP	O
pain	pain	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
motor	motor	NN	I-NP	O
vehicle	vehicle	NN	I-NP	O
accident	accident	NN	I-NP	O
around	around	IN	B-PP	O
a	a	DT	B-NP	O
year	year	NN	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
not	not	RB	B-ADVP	O
currently	currently	RB	I-ADVP	O
an	an	DT	B-NP	O
active	active	JJ	I-NP	O
issue	issue	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Congenital	Congenital	JJ	I-NP	O
partial	partial	JJ	I-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
limb	limb	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Depression	Depression	NN	I-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Dicloxacillin	Dicloxacillin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
;	;	:	O	O
Synthroid	Synthroid	JJ	B-NP	O
150	150	CD	I-NP	O
mcg	mcg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Paxil	Paxil	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
by	by	IN	B-PP	O
herself	herself	PRP	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
family	family	NN	I-NP	O
to	to	TO	B-PP	O
support	support	NN	B-NP	O
or	or	CC	O	O
close	close	JJ	B-NP	O
friends	friend	NNS	I-NP	O
since	since	IN	B-PP	O
her	her	PRP$	B-NP	O
breast	breast	NN	I-NP	O
cancer	cancer	NN	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
former	former	JJ	I-NP	O
private	private	JJ	I-NP	O
chef	chef	NN	I-NP	O
but	but	CC	O	O
lost	lose	VBD	B-VP	O
her	her	PRP$	B-NP	O
job	job	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
cancer	cancer	NN	I-NP	O
and	and	CC	O	O
spent	spend	VBD	B-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
savings	saving	NNS	I-NP	O
on	on	IN	B-PP	O
medical	medical	JJ	B-NP	O
cost	cost	NN	I-NP	O
,	,	,	O	O
because	because	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
insurance	insurance	NN	I-NP	O
.	.	.	O	O

Now	Now	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
Medicare	Medicare	NNP	I-NP	O
and	and	CC	O	O
disability	disability	NN	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
presently	presently	RB	B-ADVP	O
her	her	PRP$	B-NP	O
only	only	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
income	income	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
alcohol	alcohol	NN	B-NP	O
or	or	CC	I-NP	O
tobacco	tobacco	NN	I-NP	O
use	use	NN	I-NP	O
or	or	CC	I-NP	O
abuse	abuse	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
One	One	CD	B-NP	O
great	great	JJ	I-NP	O
aunt	aunt	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
maternal	maternal	JJ	I-NP	O
side	side	NN	I-NP	O
with	with	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
only	only	RB	B-ADVP	O
for	for	IN	B-PP	O
very	very	RB	B-NP	O
unusually	unusually	RB	I-NP	O
heavy	heavy	JJ	I-NP	O
menstrual	menstrual	JJ	I-NP	O
periods	period	NNS	I-NP	O
since	since	IN	B-PP	O
her	her	PRP$	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
,	,	,	O	O
bleeding	bleed	VBG	B-VP	O
often	often	RB	B-ADVP	O
for	for	IN	B-PP	O
10-14	10-14	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
-	-	HYPH	O	O
Temp	Temp	NN	B-NP	B-protein
97.8	97.8	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
88	88	CD	I-NP	O
and	and	CC	O	O
regular	regular	JJ	B-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
118/92	118/92	CD	I-NP	I-DNA
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

GENERAL	GENERAL	NNP	B-NP	O
-	-	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
pleasant	pleasant	JJ	I-NP	O
woman	woman	NN	I-NP	O
lying	lie	VBG	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
Oropharynx	Oropharynx	NN	I-NP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
JVP	JVP	NN	I-NP	B-protein
at	at	IN	B-PP	O
sternal	sternal	JJ	B-NP	O
angle	angle	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
thyromegaly	thyromegaly	RB	I-NP	O
.	.	.	O	O

CHEST	CHEST	NN	B-NP	O
-	-	HYPH	I-NP	O
Lungs	Lung	NNS	I-NP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
and	and	CC	I-NP	O
percussion	percussion	NN	I-NP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
coarse	coarse	NN	B-NP	O
inspiratory	inspiratory	JJ	I-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
over	over	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
scapula	scapula	NN	I-NP	O
.	.	.	O	O

HEART	HEART	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
Normal	Normal	JJ	I-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
or	or	CC	I-NP	O
rubs	rub	NNS	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
-	-	HYPH	I-NP	O
Normal	Normal	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
scar	scar	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	NN	I-NP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
old	old	JJ	I-NP	O
excisional	excisional	JJ	I-NP	O
biopsy	biopsy	NN	I-NP	O
.	.	.	O	O

BREASTS	BREASTS	NNS	B-NP	O
-	-	HYPH	B-NP	O
Diffuse	Diffuse	NN	I-NP	O
erythema	erythema	NN	I-NP	O
and	and	CC	O	O
slight	slight	JJ	B-NP	O
peau	peau	NN	I-NP	O
d'orange	d'orange	NN	I-NP	O
appearance	appearance	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
left	left	JJ	I-NP	O
breast	breast	NN	I-NP	O
with	with	IN	B-PP	O
slight	slight	JJ	B-NP	O
erythema	erythema	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
nipple	nipple	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
nipple	nipple	NN	I-NP	O
discharge	discharge	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
masses	mass	NNS	I-NP	O
or	or	CC	O	O
axillary	axillary	JJ	B-NP	O
lymph	lymph	NN	I-NP	O
nodes	node	NNS	I-NP	O
appreciated	appreciate	VBN	B-VP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
-	-	HYPH	O	O
Congenital	Congenital	JJ	B-NP	O
left	left	JJ	I-NP	O
partial	partial	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
with	with	IN	B-PP	O
upper	upper	JJ	B-NP	O
extremity	extremity	NN	I-NP	O
missing	miss	VBG	B-VP	O
below	below	IN	B-PP	O
mid	mid	JJ	B-NP	O
upper	upper	JJ	I-NP	O
arm	arm	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
cefotaxime	cefotaxime	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
concern	concern	NN	B-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
skin	skin	NN	I-NP	O
changes	change	NNS	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
prior	prior	JJ	B-NP	O
radiation	radiation	NN	I-NP	O
,	,	,	O	O
especially	especially	RB	B-VP	O
given	give	VBN	I-VP	O
its	its	PRP$	B-NP	O
distribution	distribution	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
back	back	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
Radiation/Oncology	Radiation/Oncology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
saw	see	VBD	B-VP	O
and	and	CC	O	O
followed	follow	VBD	B-VP	O
Ms.	Ms.	NNP	B-NP	O
Deluccia	Deluccia	NNP	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
very	very	RB	B-ADVP	O
strongly	strongly	RB	I-ADVP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	B-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
prior	prior	JJ	B-NP	O
radiation	radiation	NN	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
workup	workup	NN	I-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
bone	bone	NN	I-NP	O
scan	scan	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
CAT	CAT	NN	I-NP	O
scan	scan	NN	I-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
only	only	RB	B-NP	O
thick	thick	JJ	I-NP	O
skin	skin	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
breast	breast	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
adenopathy	adenopathy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
minimal	minimal	JJ	B-NP	O
lung	lung	NN	I-NP	O
fibrosis	fibrosis	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
is	be	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
fever	fever	NN	I-NP	O
or	or	CC	I-NP	O
elevated	elevated	JJ	I-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
breast	breast	NN	I-NP	O
performed	perform	VBN	B-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
collection	collection	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lateral	lateral	JJ	I-NP	O
margin	margin	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
breast	breast	NN	I-NP	O
.	.	.	O	O

Serosanguineous	Serosanguineous	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
was	be	VBD	B-VP	O
aspirated	aspirate	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
collection	collection	NN	I-NP	O
and	and	CC	I-NP	O
gram	gram	NN	I-NP	O
stain	stain	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
fluid	fluid	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
polys	poly	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
organisms	organism	NNS	I-NP	O
.	.	.	O	O

Culture	Culture	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
fluid	fluid	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
IV	IV	CD	I-NP	O
line	line	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
IV	IV	CD	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Ancef	Ancef	NN	I-NP	O
1	1	CD	I-NP	O
gm	gm	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

x14	x14	CD	B-NP	O
days	day	NNS	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Synthroid	Synthroid	JJ	I-NP	O
115	115	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Paxil	Paxil	NNP	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
To	To	TO	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
CHI	CHI	NNP	B-NP	O
SPECCHIO	SPECCHIO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
IR17	IR17	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LUPE	LUPE	NNP	B-NP	O
J.	J.	NNP	I-NP	O
GOOLESBY	GOOLESBY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
LH43	LH43	NNP	I-NP	O
IL870/5424	IL870/5424	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
95498	95498	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

EZAISF9UKR	EZAISF9UKR	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
3/4/97	3/4/97	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
6/10/97	6/10/97	CD	B-NP	O

